Nature study reports PERT genome-editing strategy to treat nonsense mutation disorders

A study published in Nature has reported a new genome-editing strategy called PERT that can potentially treat multiple genetic disorders caused by nonsense mutations. The technique introduces a modified tRNA to bypass premature stop codons.

PERT Genome-Editing Strategy:

Dimension	Key Details
Technique Name	PERT stands for Prime Editing mediated Readthrough of premature Termination codons
Target Mutation	Applies to nonsense mutations that convert a normal codon into a stop codon and stop protein synthesis early
Prevalence	Nonsense mutations account for about one fourth of known disease causing genetic changes
Mechanism	Uses normal transfer RNA to create a suppressor tRNA that bypasses early stop signals enabling full protein synthesis
Prime Editing Tool	Uses prime editing with multiple guide RNAs and a new editing enzyme PE6c for improved accuracy
tRNA Basis	Human cells contain 418 tRNA genes with leucine arginine tyrosine and serine tRNAs identified as candidates
Editing Efficiency	Reported efficiency of 60 to 80 percent compared to 10 to 20 percent in standard repair methods
Demonstrated Impact	Restored enzyme activity in Batten disease and Tay Sachs disease to 17 to 70 percent of normal levels
Safety Profile	No major off target effects or toxicity observed
Challenges	Issues in delivery to different tissues long term safety and durability and need for further clinical validation